Phase 1 EBV-Related Lymphoproliferative Disorder Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

BZLF1 Peptide Vaccine (OSU-2131) With QS-21 for the Prevention of Epstein-Barr Virus Related Cancer in Patients Awaiting Solid Organ Transplants

EBV-Related Lymphoproliferative DisorderPost-Transplant Lymphoproliferative DisorderChronic Kidney Disease Stage 5+2 more

Ohio State University Comprehensive Cancer Center55 enrolled1 locationNCT06741072

Recruiting

Phase 1

EBV Specific T-Lymphocytes for Treatment of EBV-Positive Lymphoma

EBV-Related Hodgkin LymphomaEBV-Related Lymphoproliferative DisorderEBV Related Non-Hodgkin's Lymphoma

Baylor College of Medicine52 enrolled4 locationsNCT04664179